What influence do circulating myeloma plasma cells have on the treatment of multiple myeloma?
How can MRD and disease be assessed in routine practice?
CAR T-cells: an advancement in treating MM?
Genetically modified T-cell therapy in multicenter trials
ENDEAVOUR, ASPIRE and TOURMALINE-MM1 trial results for multiple myeloma